Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case
05/17/2013 6:51AM - GlobeNewswire

GeneNews Reports Q1 2013 Financial Results
05/15/2013 5:00PM - GlobeNewswire

Genmab Announces Financial Results for the First Quarter of 2013
05/07/2013 11:08AM - GlobeNewswire

Genmab Announces Top-Line Phase II Results for Ofatumumab Combined With Bendamustine in Untreated and Relapsed Chronic Lymphocytic Leukemia
05/01/2013 12:56PM - GlobeNewswire

Daratumumab Receives Breakthrough Therapy Designation in Double Refractory Multiple Myeloma from U.S. Food and Drug Administration
05/01/2013 12:07PM - PR Newswire

Daratumumab Receives Breakthrough Therapy Designation From US Food and Drug Administration
05/01/2013 11:52AM - GlobeNewswire

Arzerra First Quarter 2013 Net Sales Figures
04/24/2013 7:11AM - GlobeNewswire

Passing of Genmab A/S' Annual General Meeting
04/17/2013 10:19AM - GlobeNewswire

Genmab Announces Final US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit
04/16/2013 2:20PM - GlobeNewswire

GeneNews Announces Annual Shareholder Meeting
04/15/2013 4:30PM - GlobeNewswire

Daratumumab Granted Fast Track Designation From U.S. Food and Drug Administration
04/02/2013 10:26AM - GlobeNewswire

GeneNews Reports Q4 and Full Year 2012 Financial Results
03/26/2013 4:30PM - GlobeNewswire

Arzerra Receives Approval in Japan
03/25/2013 2:14AM - GlobeNewswire

Genmab 2012 Annual Report
03/07/2013 11:11AM - GlobeNewswire

Genmab Announces Sale of Manufacturing Facility to Baxter
02/28/2013 1:49PM - GlobeNewswire